Eton Pharmaceuticals, Inc.ETONNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
3Y CAGR+29.7%
Studio
Year-over-Year Change

Cash generated from core business operations

3Y CAGR
+29.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$10.52M+986.1%
2024$969000.00-85.8%
2023$6.82M+41.4%
2022$4.82M+202.1%
2021$-4.72M+78.9%
2020$-22.35M-24.0%
2019$-18.03M-121.3%
2018$-8.14M-72.6%
2017$-4.72M-